Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

Teleflex Incorporated (TFX)

Compare
137.80
-1.57
(-1.13%)
At close: March 28 at 4:00:02 PM EDT
138.50
+0.70
+(0.51%)
After hours: March 28 at 6:57:17 PM EDT
Loading Chart for TFX
  • Previous Close 139.37
  • Open 138.97
  • Bid --
  • Ask --
  • Day's Range 137.17 - 139.68
  • 52 Week Range 128.55 - 249.91
  • Volume 776,395
  • Avg. Volume 1,066,369
  • Market Cap (intraday) 6.389B
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) 92.48
  • EPS (TTM) 1.49
  • Earnings Date Apr 30, 2025 - May 5, 2025
  • Forward Dividend & Yield 1.36 (0.99%)
  • Ex-Dividend Date Mar 7, 2025
  • 1y Target Est 168.21

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

www.teleflex.com

14,100

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TFX

View More

Performance Overview: TFX

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TFX
22.38%
S&P 500 (^GSPC)
5.11%

1-Year Return

TFX
38.62%
S&P 500 (^GSPC)
6.22%

3-Year Return

TFX
59.28%
S&P 500 (^GSPC)
21.97%

5-Year Return

TFX
49.91%
S&P 500 (^GSPC)
119.59%

Compare To: TFX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TFX

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    6.39B

  • Enterprise Value

    7.85B

  • Trailing P/E

    92.48

  • Forward P/E

    9.86

  • PEG Ratio (5yr expected)

    0.18

  • Price/Sales (ttm)

    2.13

  • Price/Book (mrq)

    1.49

  • Enterprise Value/Revenue

    2.58

  • Enterprise Value/EBITDA

    18.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.29%

  • Return on Assets (ttm)

    3.69%

  • Return on Equity (ttm)

    1.61%

  • Revenue (ttm)

    3.05B

  • Net Income Avi to Common (ttm)

    70.16M

  • Diluted EPS (ttm)

    1.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    306.16M

  • Total Debt/Equity (mrq)

    41.43%

  • Levered Free Cash Flow (ttm)

    435.95M

Research Analysis: TFX

View More

Company Insights: TFX

Research Reports: TFX

View More

People Also Watch